Dr. Reddy’s rolls out generic of Plaquenil
HYDERABAD, India and PRINCETON, N.J. — Dr. Reddy’s Laboratories announced the launch of hydroxychloroquine sulfate tablets USP, 200 mg, a therapeutic equivalent generic version of Plaquenil (hydroxychloroquine sulfate) tablets, in the U.S. market, approved by the U.S. Food and Drug Administration. The Plaquenil brand and generic had U.S. sales of approximately $215 million MAT for
